The association between FLT3 (Fms Related Receptor Tyrosine Kinase 3) and Chronic Myelomonocytic Leukemia is supported by expert-curated evidence, drawing on a single expert-curated source, which records likely-pathogenic variants.
Sources1
Clinical variants0
Symptoms3
Compounds3
Trials110of 1,087 via FLT3 compounds
Publications6
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.